top of page

News & Insights

Biosimilars reimagined: faster, smarter, patient-ready

Biosimilars reimagined: faster, smarter, patient-ready

Biosimilar Development in 2026 and Beyond

How data-driven health equity can fix the science and speed access

How data-driven health equity can fix the science and speed access

Building Health Equity Into Clinical Research Strategy: Turning Mission Into Measurable Impact

Rubix LS: Driving Ethical, Compliant, and Data-Driven Research at Scale

Rubix LS: Driving Ethical, Compliant, and Data-Driven Research at Scale

Rubix LS: Driving Ethical, Compliant, and Data-Driven Research at Scale

The Hidden Costs of Vendor Fragmentation in Clinical Development

The Hidden Costs of Vendor Fragmentation in Clinical Development

The Hidden Costs of Vendor Fragmentation in Clinical Development

Turning compliance challenges into clinical trial strengths.

Turning compliance challenges into clinical trial strengths.

Clinical Trial Compliance Challenges and How to Overcome Them

Proof That Macrobiological Equity Strengthens Clinical Trials Through Real-World Application

Proof That Macrobiological Equity Strengthens Clinical Trials Through Real-World Application

Proof That Macrobiological Equity Strengthens Clinical Trials Through Real-World Application

Embedding Macrobiological Equity into Clinical Trial Design through Clinicoequity

Embedding Macrobiological Equity into Clinical Trial Design through Clinicoequity

Embedding Macrobiological Equity into Clinical Trial Design through Clinicoequity

Designing trials that reflect the real world.

Designing trials that reflect the real world.

How Macrobiological Inequities Shape Clinical Trial Design

Clinical trials does not equal Clinical Research

Clinical trials does not equal Clinical Research

Clinical trials does not equal Clinical Research

Public Health Data: The Key to Building More Inclusive Clinical Trials

Public Health Data: The Key to Building More Inclusive Clinical Trials

Public Health Data: The Key to Building More Inclusive Clinical Trials

The FDA’s Replimune Rejection: A Wake-Up Call for Smarter Procurement & Clinical Strategy

The FDA’s Replimune Rejection: A Wake-Up Call for Smarter Procurement & Clinical Strategy

The FDA’s Replimune Rejection: A Wake-Up Call for Smarter Procurement & Clinical Strategy

Project Panacea: Where Synthetic Bio Meets Real-World Impact

Project Panacea: Where Synthetic Bio Meets Real-World Impact

Project Panacea: Where Synthetic Bio Meets Real-World Impact

Optimizing Clinical Trial Design for Quicker FDA Approval

Optimizing Clinical Trial Design for Quicker FDA Approval

Optimizing Clinical Trial Design for Quicker FDA Approval

bottom of page